High Vista Strategies LLC Relay Therapeutics, Inc. Transaction History

High Vista Strategies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $969,509 - $1.77 Million	-97,048 Reduced 75.09%	32,197 $404,000
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $709,140 - $1.08 Million	-47,276 Reduced 26.78%	129,245 $2.13 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $129,394 - $219,494	9,138 Added 5.46%	176,521 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $977,044 - $1.7 Million	54,070 Added 47.72%	167,383 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $595,023 - $1.56 Million	44,705 Added 65.16%	113,313 $1.9 Million

Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $458,200 - $731,853	22,616 Added 49.17%	68,608 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $214,474 - $305,460	8,249 Added 21.86%	45,992 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $431,166 - $550,589	14,493 Added 62.34%	37,743 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $175,285 - $243,423	6,374 Added 37.77%	23,250 $851,000
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $61,820 - $116,968	1,901 Added 12.69%	16,876 $583,000
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $531,762 - $809,099	14,975 New	14,975 $622,000

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $779M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.